Evergreen Telehealth Logo
Back to Home

Health & Wellness Learn

Expert insights, latest research, and evidence-based guidance for your wellness journey

Company Update

A Note From Evergreen on the July 2026 PCAC Peptide Review

7/25/2026

Featured
BPC-157 Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
BPC-157 Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
PCAC voted 8-6 to recommend BPC-157 for the FDA Section 503A Bulks List. Compounding is not yet legal — here's exactly where things stand.
Evergreen Editorial
7/25/2026
Read Full Article
KPV Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
KPV Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
PCAC voted to recommend KPV for the FDA Section 503A Bulks List. Compounding is not yet legal — here's exactly where things stand.
Evergreen Editorial
7/25/2026
Read Full Article
Now Trending
DSIP (Emideltide) Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
DSIP (Emideltide) Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
PCAC voted against recommending DSIP (Emideltide) for the FDA Section 503A Bulks List. Compounding is not authorized — here's where things stand.
Evergreen Editorial
7/25/2026
Read Full Article
MOTS-c Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
MOTS-c Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
PCAC voted to recommend MOTS-c for the FDA Section 503A Bulks List. Compounding is not yet legal — here's exactly where things stand.
Evergreen Editorial
7/25/2026
Read More
Semax Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
Semax Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
PCAC voted to recommend Semax for the FDA Section 503A Bulks List. Compounding is not yet legal — here's exactly where things stand.
Evergreen Editorial
7/25/2026
Read More
Epitalon Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
Epitalon Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
PCAC voted to recommend Epitalon for the FDA Section 503A Bulks List. Compounding is not yet legal — here's exactly where things stand.
Evergreen Editorial
7/25/2026
Read More
TB-500 Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
TB-500 Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means
PCAC voted to recommend TB-500 for the FDA Section 503A Bulks List. Compounding is not yet legal — here's exactly where things stand.
Evergreen Editorial
7/25/2026
Read More

Stay Informed About Your Health

Get the latest insights on wellness, treatment options, and health optimization delivered directly to your inbox.